Loading asset research
Q3 2026 earnings · Nov 4
Context Therapeutics Inc. Common Stock
CNTXNasdaq · USD · StocksQuote as of · Exchange session not verified$0.371
-3.13%
Today
CNTX
Loading 1D prices…
Market cap
$32.5M
Volume
880.2K
52w high
$3.6252w low
$0.343Company profile
Context Therapeutics Inc. Common Stock
Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of solid tumors. The company's product candidate includes CTIM-76, a Claudin 6 (CLDN6) x CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. It has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
PHILADELPHIA, PA, United States
Employees
15
Fiscal year end
1231
CIK
1842952
Session & valuation
Open$0.38
Previous close$0.383
Day high$0.389
Day low$0.363
30-day avg. volume1.8M
Outstanding shares91.9M
Diluted EPS-$0.38
Latest annual period
P/E (trailing)-0.98
P/E (forward)-0.81
Price / book0.85
Beta1.69
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| CPHIChina Pharma Holdings Inc. Common Stock | $32.7M | $4.1M | -76.91% | -$0.74 | +2.78% | Unrated |
| BHSTBioHarvest Sciences Inc. Common Stock | $33.1M | $34.5M | -32.27% | -$0.60 | -0.68% | Buy |
| RMTIRockwell Medical Inc. Common Stock | $33.9M | $69.3M | -7.67% | -$0.15 | 0.00% | Buy |
| ABVCABVC BioPharma Inc. Common Stock | $30.4M | $0.00 | — | -$0.39 | -0.96% | Unrated |
| BYSIBeyondSpring Inc. Ordinary Shares | $30M | $0.00 | — | -$0.02 | -0.28% | Unrated |